Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
James Glasbey(National Institute for Health and Care Research), Ian Ganyli(Memorial Sloan Kettering Cancer Center), Dmitri Nepogodiev, Samuel Ford(University Hospitals Birmingham NHS Foundation Trust), Helen Mohan(Merck KGaA, Darmstadt (Germany)), Keith Roberts(University of Alabama at Birmingham Hospital), Siobhan McKay(Queen Elizabeth Hospital Birmingham), Mohamad K. Abou Chaar(Mayo Clinic), Raghavan Vidya, Richard Shaw(University of Liverpool), Elizabeth Li, Ewen A. Griffiths(Queen Elizabeth Hospital Birmingham), Joana Simões, Sudha Sundar(Sandwell & West Birmingham Hospitals NHS Trust), Rohan R Gujjuri, Ian Ganly(Memorial Sloan Kettering Cancer Center), Grant D. Stewart(University of Cambridge), Aneel Bhangu, Angelos G. Kolias(University of Cambridge), Omar M. Omar(SIMAD University), Marco Fiore(Instituto Português de Oncologia Francisco Gentil), PGDME(Queen Mary University of London), Jonathan P Evans(Nottingham University Hospitals NHS Trust), Jonathan G. Edwards(Merck KGaA, Darmstadt (Germany)), Anant Desai, Carlos San Miguel-Méndez(Merck KGaA, Darmstadt (Germany)), Jose Flavio Videria(Instituto Português de Oncologia Francisco Gentil), Mary L Venn(Association for Cancer Surgery), Haytham M.A. Kaafarani(Harvard University), Neil Smart(Royal Devon & Exeter NHS Foundation Trust)
Cited by 223
Related Papers
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
|The Lancet|2020|1.8k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
|Cancer Cell|2018|591